For how we live.
In nearly 40,000 UK women, abnormal blood pressure six weeks after a hypertensive pregnancy roughly doubled later cardiovascular disease. A Dutch cohort shows pregnancy history sharpens risk prediction.
A final rule amends 80 FDA standards of identity so makers can replace some or all added salt with substitutes, part of a push to cut sodium tied to high blood pressure. It takes effect 14 December 2026.
Across 27 trials and 88,830 people, each 10-mmHg drop in systolic pressure cut cardiovascular events whether or not the kidneys were impaired — while aggressive lowering nudged up short-term markers of kidney decline.
A Korean cohort of 1.37 million women found more dementia after hypertensive pregnancies. The association did not survive adjustment for the vascular and metabolic conditions that followed.
Added to an SGLT2 inhibitor, the aldosterone-synthase inhibitor cut office systolic pressure 7.5 mm Hg and albuminuria about a quarter in 59 adults with CKD. Kidney function dipped slightly; the maker funded it.
In the phase 3 Bax24 trial, the aldosterone-synthase inhibitor cut 24-hour ambulatory systolic pressure 14.0 mm Hg more than placebo over 12 weeks. AstraZeneca funded it, and three patients developed high potassium.
Garlic supplements modestly lower blood pressure in hypertensive people, and may nudge cholesterol down a little. The cold-prevention evidence rests on a single trial, and no study shows garlic prevents heart attacks.
Beetroot juice really does lower blood pressure — the effect is one of the better-documented in food science, driven by dietary nitrate. But most trials are short and small, and no study shows it prevents heart attacks.
The Global Burden of Disease 2023 study estimates 2.33 billion NCD incident cases and 263 million DALYs across Africa, with high blood pressure the single largest driver of the continent's NCD deaths.
Eating more potassium lowers blood pressure in people who already have hypertension, and a large trial of potassium-enriched salt cut strokes and deaths — but the benefit is not for everyone.
Pooled trials show a genuine but small fall in blood pressure, around 2 mmHg. The bigger pitches — sleep, cramps, energy, anxiety — run ahead of the evidence.
A landmark trial pushed blood pressure hard and cut mild cognitive impairment — but its headline dementia result fell short of significance after the study stopped early. The pooled trial evidence is real, and modest.
Pooled randomised trials show caffeine pushes blood pressure up sharply in the hour after a dose. But when the caffeine arrives as coffee, and over weeks rather than minutes, the effect shrinks toward nothing.
Federal statistics put 18.3 million households short of food last year. A 57,404-person cohort links lower food security to higher premature mortality and years of lost life expectancy.
A large treadmill cohort found the least-fit adults had about five times the death rate of the fittest — a bigger risk than coronary disease, smoking or diabetes. But it measures a state, not a lever.
A meta-analysis of four small trials found zilebesiran lowered office systolic pressure by 7.16 mmHg versus placebo, with wide confidence intervals, a hint the effect wanes by six months, and more hyperkalaemia.
A pooled analysis of 315,403 adults finds wealth inequalities in hypertension, diabetes and cholesterol care grow across the care cascade — but the biggest treatment gaps are not where most heart risk could be averted.
Out-of-office readings predict heart attacks and death better than a clinic measurement, and guidelines now require them to confirm hypertension — but only a validated upper-arm cuff counts.
Two controlled-feeding trials found a diet rich in fruit, vegetables and low-fat dairy lowered blood pressure, most in people who already had hypertension, and more still when sodium was cut.
A WHO data-set analysis shows how mobile and hospital teams split the load of hypertension, diabetes and epilepsy care during the war, while a separate study tracked dialysis capacity falling.
Applying the 2025 AHA/ACC guideline to a Nigerian survey sharply raised the share classified hypertensive versus older criteria, widening the gap between diagnosis and treatment capacity.
THESUS-HF II enrolled 1,578 patients across 50 hospitals in 17 countries. Guideline drugs were prescribed at discharge in most patients, and target doses were reached in fewer than half.
European hypertension specialists found only two wrist-cuff blood pressure watches with validation studies done to established protocols. A sleep group ran a Galaxy Watch against two nights of polysomnography.
A 2023 network meta-analysis of 270 trials ranked isometric exercise first for lowering resting blood pressure. Two 2026 analyses, using ambulatory monitoring and a larger trial set, rank it among the weakest.
A prospective study of 660 Syrian refugees living with noncommunicable diseases found symptom burden peaked in the hottest, dustiest period — with asthma and hypertension carrying the highest risk.
Global mean intake was 4,278 mg a day in 2021 against a recommended limit under 2,000. A week of low-sodium eating moved blood pressure in most people; a five-year trial of salt substitute cut strokes.
In the phase 3 Launch-HTN trial, adults already on two to five drugs fell 9.1 mm Hg further on lorundrostat than placebo — the second aldosterone-synthase inhibitor to post positive data after baxdrostat.
Across 89,573 accelerometer-monitored adults and 678 conditions, no disease showed a significant difference between activity concentrated in one or two days and activity spread through the week.
Twenty months of under-mattress sensor data from 95,819 people found that chronic irregularity was common, persistent, and tracked with 46% higher odds of hypertension.
Two cohorts published ten days apart. One found the PFAS mixture more than doubling the odds of hypertension at 24 to 28 weeks; the other found lower birth weight, but only in female infants.
A dose-response analysis of 23 cohort studies found hypertension risk climbing steadily with intake. Stopping for a month, a separate study found, dropped systolic pressure by nearly 7%.
A UK Biobank analysis broke ultra-processed food into 37 specific ingredients rather than treating it as one block. Flavours, colourings, sweeteners and sugars carried the signal; processing aids and added fibre did not.
American guidelines call 130/80 stage 1 hypertension. European ones call the same reading elevated blood pressure and not yet disease. The measurement did not change. The label did.
After four weeks, the comorbid-insomnia group's blood pressure fell 20 points more than the apnea-only group. The finding flips the usual framing of COMISA as simply a worse-outcomes phenotype.
In moderate-to-heavy drinkers who stopped for a month, insulin resistance fell by a quarter and two cancer-related growth factors dropped sharply — changes a matched control group did not show.
In 377 patients, hypoxic burden — a metric combining how often, how deep, and how long oxygen drops — tracked with abnormal nighttime blood pressure patterns where conventional measures didn't.
In 230 adults followed a year, lower heart-rate variability and less moderate-to-vigorous activity at baseline were independently linked to developing hypertension. It is a risk signal, in one unreplicated cohort.
Pooling a decade of research on women with hypertension, diabetes and obesity, researchers found modest blood pressure and metabolic shifts only in select high-risk subgroups.
Baxdrostat blocks the enzyme that makes aldosterone, rather than blocking aldosterone's receptor. In a 794-patient trial it lowered systolic pressure another 10 points in people already on multiple drugs.
Pooled data across 38 studies found higher coffee intake linked to a higher risk of heart attack — but a lower risk of stroke and irregular heartbeat, with a separate benefit for people with high blood pressure.
A Qatar Biobank analysis derived local cut-points and found WHO's standard numbers misclassified more than half of men and nearly half of women in the sample.
A 20-point rise in apnea severity tracked with about three times more blood pressure increase in adults with a BMI of 20 than in those with a BMI of 30, flipping a common assumption.
A survey-based analysis of the European Health Interview Survey puts a price on Europe's obesity-related hospital use, and finds the strongest single association is not with obesity at all.
A February scientific statement declines to recommend the category for clinical decisions. Six weeks earlier, a journal retracted a validation study of a popular consumer model.
FDA-cleared in September 2025, the feature notifies fewer than half of people with hypertension in Apple's own validation. Hypertension specialists warn the bigger risk is false reassurance.
In a Pennsylvania cohort followed 7.5 years, the combination carried the highest risk when insomnia came with objectively short sleep. Insomnia with normal sleep duration showed no significant association.
The FDA's revised general wellness policy lets non-invasive devices infer blood pressure, glucose and other physiologic parameters. The regulated line is no longer the measurement — it is the sentence next to it.
A mirror that scores physiological age in 30 seconds. A watch that watches your gait for dementia. The gap between what these products measure and what they imply is the story of the show.
Among 1,000 adults in Mwanza, overnight oximetry found sleep apnea in 17% of people with HIV and 19% without. Excessive daytime sleepiness, oddly, was more common in those without HIV.
In a 774-person randomised trial, community health workers delivering medication at home nearly doubled the share of patients whose blood pressure was controlled at six months.
A meta-analysis of pedometer, tracker and smartwatch interventions lasting 12 to 48 weeks found no significant change in systolic or diastolic pressure — nor in weight, glucose or HbA1c.
Applying prevalence figures to UN population data yields 852 million adults with insomnia. Only 31 of 237 countries had a usable national estimate of their own.